Atg5-deficient mesenchymal stem cells protect against non-alcoholic fatty liver by accelerating hepatocyte growth factor secretion
Abstract Background/aims Mesenchymal stem cells (MSCs) have shown promising therapeutic potential in treating liver diseases, such as non-alcoholic fatty liver disease (NAFLD). Genetic modification has been employed to enhance the characteristics of MSCs for more effective disease treatment. Here, w...
Saved in:
| Main Authors: | Caifeng Zhang, Juanjuan Ji, Xuefang Du, Lanfang Zhang, Yaxuan Song, Yuyu Wang, Yanan Jiang, Ke Li, Tingmin Chang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Cell Communication and Signaling |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12964-024-01950-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tetrahymena ATG8 homologs, TtATG8A and TtATG8B, are responsible for mitochondrial degradation induced by starvation
by: Shinya Matsuda, et al.
Published: (2025-06-01) -
Emerging roles of ATG7 in human health and disease
by: Jack J Collier, et al.
Published: (2021-11-01) -
Intervention Potential of a Recombinant Tarim Red Deer HGF Protein in a Mouse Model of Alcoholic Liver Disease
by: Hong Chen, et al.
Published: (2025-06-01) -
Upregulated ATG4B predicts poor prognosis and correlates with angiogenesis in osteosarcoma
by: Elzahraa Ibrahim Mohamed Khalil, et al.
Published: (2025-04-01) -
Involvement of the E2-like enzyme Atg3 in fungal development and virulence of Botryosphaeria dothidea
by: Wenjiao Han, et al.
Published: (2025-08-01)